Le rapport
Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde
307 rapports et plus encore
Azafaros Raises $146M Series B to Transform Biotech
Azafaros has secured $146M Series B in funding to accelerate growth and innovation in the biotech sector. Specialty pharmaceutical company advancing nizubaglustat for Gaucher disease and Parkinson's disease...
Latigo Biotherapeutics Raises $135M Series A to Transform Biotech
Latigo Biotherapeutics has secured $135M Series A in funding to accelerate growth and innovation in the biotech sector. Pain management company developing non-opioid therapies for chronic pain conditions...
COUR Pharmaceuticals Raises $105M Series A to Transform Biotech
COUR Pharmaceuticals has secured $105M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage immunology company developing nanoparticle-based therapies for celiac disease and autoimmune conditions...
TORL BioTherapeutics Raises $96M Series C to Transform Biotech
TORL BioTherapeutics has secured $96M Series C in funding to accelerate growth and innovation in the biotech sector. Immunology company developing T cell engager therapies for cancer and autoimmune diseases...
NRG Therapeutics Raises $50M Series B to Transform Biotech
NRG Therapeutics has secured $50M Series B in funding to accelerate growth and innovation in the biotech sector. Gene therapy company developing treatments for Parkinson's disease and amyotrophic lateral sclerosis (ALS)...
Peptilogics Raises $78M Series B2 to Transform Biotech
Peptilogics has secured $78M Series B2 in funding to accelerate growth and innovation in the biotech sector. Peptide therapeutics company developing macrocyclic peptides for challenging drug targets...
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Tubulis Raises $361M Series C to Transform Biotech
Tubulis has secured $361M Series C in funding to accelerate growth and innovation in the biotech sector. Antibody-drug conjugate platform company developing next-generation targeted cancer therapies...
Eikon Therapeutics Raises $350.7M Series D to Transform Biotech
Eikon Therapeutics has secured $350.7M Series D in funding to accelerate growth and innovation in the biotech sector. Drug discovery company using advanced microscopy and computation to observe protein dynamics in living cells...
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.